Robert Plenge, M.D., Ph.D.
Board Member
Biomarin Pharmaceutical Inc (BMRN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Plenge, M.D., Ph.D.
Robert Plenge, M.D., Ph.D. is recorded as Board Member at Biomarin Pharmaceutical Inc (BMRN). Biomarin Pharmaceutical Inc reported in an 8-K filed September 14, 2026 that Robert Plenge, M.D., Ph.D. was appointed to the Board, effective September 10, 2026.
“On September 10, 2026, the Board of Directors (the Board) of BioMarin Pharmaceutical Inc. (the Company) increased the size of the Board from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., to the Board, to be effective September 10, 2026 (the Appointment Date).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biomarin Pharmaceutical Inc
Other people whose current roles at this company are on record from its filings.
- Alexander Hardy CEO, Board Member
- Richard A. Meier Chairman
- Brian Mueller CFO
- Daniel Spiegelman CFO
- Dr. C. Greg Guyer CTO
- G. Eric Davis General Counsel
- Andrea Acosta Chief Accounting Officer
- Rashmi Ramchandani Chief Accounting Officer
- Athena Countouriotis Board Member
- Barbara Bodem Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.